Happy to share our latest work published today in @natcomms.nature.com We leverage #ai enhanced microscopy guided #maldi #msimaging to delineate #amyloid plaque polymorphism in #Alzheimers Fantastic collaboration with @michaelschoell.bsky.social and @tammarynlashley.bsky.social rdcu.be/ejcHj

📣 Breaking News European Medicines Agency has decided to approve lecanemab for early Alzheimer’s with some restrictions. This follows and mirrors a positive MHRA decision earlier in the year. These treatments are modest at best but do represent some progress were making in Alzheimer’s research.

I have created a starter pack of UCL people and accounts on here. Please share and if you are currently affiliated to UCL, please let me know if you would like to be added. go.bsky.app/F2fnEWt